Smiths Medical MD, Inc., of St. Paul, Minn., has received clearance for new software features on its CozMore insulin technology system.
Adding spironolactone to an ACE inhibitor or angiotensin II receptor blocker (ARB) is associated with a marked and sustained antiproteinuric effect in type 2 diabetics, researchers in the Netherlands found.
As part of an effort by the FDA and the Federal Trade Commission to halt deceptive online advertisements and sales of products misrepresented as diabetes cures or treatments, the agencies have sent approximately 180 letters and advisories to Internet outlets in the United States, Mexico, and Canada.
Treatment with a gonadotropin-releasing hormone (GnRH) agonist is associated with increased risks of diabetes, coronary heart disease (CHD), MI, and sudden cardiac death in men with prostate cancer, according to an observational study at Harvard Medical School in Boston.
Patients with diabetic nephropathy who are candidates for kidney or kidney- pancreas transplantation should be screened routinely with coronary angiography, researchers in Norway conclude.